Vision and Leadership Science and Pipeline Commitment Investors People Careers Contact the lives of individuals with rare neurological diseases Contact Privacy Policy Terms & Conditions Agreement Community Guidelines Third-Party Websites © Copyright 2021 Ovid Therapeutics. Ovid, Ovid Therapeutics, Ovid Therapeutics Inc., and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved. COVID-19 update: The safety of our communities is paramount. See our ongoing response »

Vision and Leadership Science and Pipeline Commitment Investors People Careers Contact boldcommitment Expanded Access Program Contact Privacy Policy Terms & Conditions Agreement Community Guidelines Third-Party Websites © Copyright 2021 Ovid Therapeutics. Ovid, Ovid Therapeutics, Ovid Therapeutics Inc., and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved. COVID-19 update: The safety of our communities is paramount. See our ongoing response »

Vision and Leadership Science and Pipeline Commitment Investors People Careers Contact people be bold with us There’s a difference between developing a drug and creating a medicine. And that difference is Ovid. To us, bringing a medicine to life means truly understanding the physical and emotional healing power it will have in the lives of individuals with rare neurological diseases and their families—a purpose that defines us as a company, and what makes us bold. Each and every one of us exemplifies our core value of what we call “Optinacious”—a hybrid of ‘Optimistic’ and ‘Tenacious’. Here, we foster the appetite for growth and knowledge-sharing while making the unattainable, attainable in rare neurological diseases. This is BoldMedicine. Contact Privacy Policy Terms & Conditions Agreement Community Guidelines Third-Party Websites © Copyright 2021 Ovid Therapeutics. Ovid, Ovid Therapeutics, Ovid Therapeutics Inc., and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved. COVID-19 update: The safety of our communities is paramount. See our ongoing response »

Vision and Leadership Science and Pipeline Commitment Investors People Careers Contact science Science Pipeline Clinical Studies Partners Angelman syndrome studies Fragile X studies Rare DEE studies CDKL5 deficiency disorder and Dup15q syndrome studies Dravet syndrome and Lennox-Gastaut syndrome studies Contact Privacy Policy Terms & Conditions Agreement Community Guidelines Third-Party Websites © Copyright 2021 Ovid Therapeutics. Ovid, Ovid Therapeutics, Ovid Therapeutics Inc., and BoldMedicine are trademarks of Ovid Therapeutics Inc. All rights reserved. COVID-19 update: The safety of our communities is paramount. See our ongoing response »